ConductScience.org, home

Paper825477

Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.

Pross HF and 1 other. Int J Cancer, 1976. Cited by 263 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease. Papers, record 825477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/825477

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.
PubMed
Journal
Int J Cancer
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
263
iCite
Relative citation ratio, by iCite
6.71
iCite
Revised in PubMed
2019-07-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pross HFH F
2Baines MGM G

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunity, CellularMajor topic
Leukemia, LymphoidMajor topic
LymphocytesMajor topic
Mast-Cell SarcomaMajor topic
Adult
Aged
Animals
B-Lymphocytes
Cell Line
Complement System Proteins
Cytotoxicity Tests, Immunologic
Humans
Hypersensitivity, Delayed
Immunoglobulin Fc Fragments
Leukemia, Myeloid
Middle Aged
Neoplasm Metastasis
Sarcoma, Experimental
T-Lymphocytes

Source PubMed

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.

PMIDTitleJournalYearIn PapersSource
38,882,209Natural killer cells in cancer immunotherapy.MedComm (2020)2024https://conductscience.org/library/papers/38882209PubMed
34,445,750Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.Int J Mol Sci2021https://conductscience.org/library/papers/34445750PubMed
34,017,344Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity.Front Immunol2021https://conductscience.org/library/papers/34017344PubMed
32,733,432NK Cell Development in Times of Innate Lymphoid Cell Diversity.Front Immunol2020https://conductscience.org/library/papers/32733432PubMed
27,262,776Low intensity vibration mitigates tumor progression and protects bone quantity and quality in a murine model of myeloma.Bone2016https://conductscience.org/library/papers/27262776PubMed
27,007,115Ionomycin Treatment Renders NK Cells Hyporesponsive.PLoS One2016https://conductscience.org/library/papers/27007115PubMed
24,941,370Natural killer activity: early days, advances, and seminal observations.Crit Rev Oncog2014https://conductscience.org/library/papers/24941370PubMed
18,368,320Preventive effect of a traditional herbal medicine, Hochu-ekki-to, on immunosuppression induced by surgical stress.Surg Today2008https://conductscience.org/library/papers/18368320PubMed
12,732,987Change in mitochondrial membrane potential in peripheral blood lymphocytes, especially in natural killer cells, is a possible marker for surgical stress on the immune system.World J Surg2003https://conductscience.org/library/papers/12732987PubMed
8,422,669Prognostic value of non-MHC-restricted killer cell activity in lung cancer.Cancer Immunol Immunother1993https://conductscience.org/library/papers/8422669PubMed
8,125,271Genetics of life span in mice.Genetica1993https://conductscience.org/library/papers/8125271PubMed
7,690,772Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.J Clin Invest1993https://conductscience.org/library/papers/7690772PubMed
7,389,219Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.Clin Exp Immunol1980https://conductscience.org/library/papers/7389219PubMed
7,334,070Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.J Clin Immunol1981https://conductscience.org/library/papers/7334070PubMed
7,138,766Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease.Br J Cancer1982https://conductscience.org/library/papers/7138766PubMed
7,114,924Natural killer cell activity in untreated systemic lupus erythematosus.Ann Rheum Dis1982https://conductscience.org/library/papers/7114924PubMed
7,061,569Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.J Cancer Res Clin Oncol1982https://conductscience.org/library/papers/7061569PubMed
7,002,768The effect of BCG stimulation on natural cytotoxicity in the rat.Immunology1980https://conductscience.org/library/papers/7002768PubMed
6,978,346Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity.J Clin Immunol1982https://conductscience.org/library/papers/6978346PubMed
6,976,792Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.Br J Cancer1981https://conductscience.org/library/papers/6976792PubMed

See all 66 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/825477

GET https://conductscience.org/api/papers/v1/825477/cited_by?page=2